50 related articles for article (PubMed ID: 22290994)
1. Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine.
Gentil V; Lotufo-Neto F; Andrade L; Cordás T; Bernik M; Ramos R; Maciel L; Miyakawa E; Gorenstein C
J Psychopharmacol; 1993 Jan; 7(4):316-24. PubMed ID: 22290994
[TBL] [Abstract][Full Text] [Related]
2. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
3. Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects.
Marcourakis T; Gorenstein C; Gentil V
J Psychopharmacol; 1993 Jan; 7(4):325-30. PubMed ID: 22290995
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
6. Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
[TBL] [Abstract][Full Text] [Related]
7. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
8. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
[TBL] [Abstract][Full Text] [Related]
9. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
10. Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.
Cassano GB; Petracca A; Perugi G; Nisita C; Musetti L; Mengali F; McNair DM
J Affect Disord; 1988; 14(2):123-7. PubMed ID: 2966825
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
12. Is buspirone effective for panic disorder?
Sheehan DV; Raj AB; Sheehan KH; Soto S
J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
[TBL] [Abstract][Full Text] [Related]
13. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
15. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
16. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
Mavissakalian M; Michelson L
J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
[TBL] [Abstract][Full Text] [Related]
17. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
Pecknold JC; Luthe L; Iny L; Ramdoyal D
J Psychiatry Neurosci; 1995 May; 20(3):193-8. PubMed ID: 7786880
[TBL] [Abstract][Full Text] [Related]
20. Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side effects.
Svebak S; Cameron A; Levander S
J Clin Psychiatry; 1990 May; 51 Suppl():14-7; discussion 50-3. PubMed ID: 2186020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
